Venmax Drugs And Pharmaceuticals informs about financial results

15 Nov 2018 Evaluate

In compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Venmax Drugs And Pharmaceuticals has informed about the un-audited Financial Results of the company for the 2nd and half year ended September 30, 2018, as approved by the Board of Director at their meeting held today i.e. 14th November, 2018 at 4.00 P M and concluded at 4.45 PM.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

29.21 1.39 (5.00%)
29-Apr-2025 14:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.90
Dr. Reddys Lab 1180.35
Cipla 1542.45
Lupin 2075.00
Zydus Lifesciences 890.15
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...